Is Hers legit?

Who actually operates it

San Francisco, CA

What third-party reviewers say

Hers (forhers.com) holds a middling Trustpilot TrustScore of 3.4 across several thousand reviews and parent company Hims & Hers is BBB-accredited, but third-party sentiment skews negative on operations: PissedConsumer rates it 1.8/5 with recurring complaints about unauthorized charges, hard-to-cancel subscriptions, refused refunds, and slow support. Those same complaint themes are now the subject of a pending federal case: on July 29, 2026 the FTC, Utah and California sued parent Hims & Hers Health, Inc. over its subscription billing, cancellation flow and health-data sharing (allegations, not findings; case status Pending). Separately, the FDA has criticized its compounded-semaglutide weight-loss marketing as 'false or misleading.'

Reddit sentiment (mixed): Discussion is dominated by regulatory news (FDA called Hers' compounded-semaglutide marketing 'false or misleading') and consumer billing complaints; positive efficacy stats circulating are company-published, not independent user reviews.

Trustpilot verified June 19, 2026, external-reviews verification pass..

What people complain about with Hers

• •Pending federal enforcement action against the parent company. On July 29, 2026 the FTC, joined by Utah and California acting through Los Angeles County Counsel, filed a complaint against Hims & Hers Health, Inc. in the U.S. District Court for the Northern District of California, alleging violations of the FTC Act and the Restore Online Shoppers' Confidence Act over subscription billing, cancellation friction, and sharing consumer health information with advertising platforms. Case status is Pending. These are allegations, not findings.
• •Membership + medication are billed separately ($39 first month / $149 ongoing membership), so total both line items before comparing prices
• •Support runs at big-platform scale, fine for routine refills, less personal if you want high-touch care
• •Compounded pricing starts at $199/mo with stepped pricing at higher doses, budget for the dose you'll end up on, not the entry dose
• •Zepbound access priced at ~$1,899/mo (brand cash) via the Lilly partnership, read as access, not value

Our verdict

The 2026 Novo Nordisk partnership makes Hers materially different from where it was a year ago, FDA-approved Wegovy pen and pill from $149/mo is one of the cheapest brand-name GLP-1 routes available. Compounded semaglutide stays at $199/mo, and compounded tirzepatide and Zepbound are now on the menu. Best for women who want brand-name access at competitive pricing inside a female-focused platform; if that's you, start with the Wegovy funnel.